<?xml version="1.0" encoding="UTF-8"?>
<p>The scale-up of antiretroviral therapy to all pregnant and breastfeeding women living with HIV, known as Option B+, has the potential to dramatically improve maternal health and end mother-to-child HIV transmission (MTCT) [
 <xref rid="pone.0227935.ref001" ref-type="bibr">1</xref>]. In Malawi, all pregnant women diagnosed with HIV in antenatal care (ANC) begin lifelong antiretroviral therapy (ART) under Option B+ [
 <xref rid="pone.0227935.ref002" ref-type="bibr">2</xref>]. However, women who initiate ART during pregnancy under Option B+ are one-fifth as likely to return to HIV care after their initial visit compared to non-pregnant women initiating ART in Malawi [
 <xref rid="pone.0227935.ref003" ref-type="bibr">3</xref>]. In the short term, poor maternal mental health has the potential to undermine the delivery of Option B+ by affecting initiation of and retention in HIV care [
 <xref rid="pone.0227935.ref004" ref-type="bibr">4</xref>]. Long term, poor maternal mental health and disrupted HIV care may increase the risk of MTCT and have negative effects on womenâ€™s quality of life and psychological well-being [
 <xref rid="pone.0227935.ref004" ref-type="bibr">4</xref>].
</p>
